Tuesday, June 7, 2016

BRIEF-Cytori completes enrollment in U.S. phase III scleroderma trial

* Cytori announces enrollment completion in U.S. Phase III

scleroderma trial

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)